Definium Therapeutics, Inc. Common Shares — Graphique, cours et actualités (NASDAQ:DFTX)

Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques

Trimestriel Annuel

Market Capitalization 2.64 B
Employee 106
Founded 2010
CEO Robert Barrow
Website www.definiumtx.com
Headquarter British Columbia, Canada
FIGI BBG00F13HYQ7
Industry Biotechnologies

Chiffre d'affaires total

Résultat net

Bénéfice par action de base (BPA de base)

Dette totale

Flux de trésorerie disponible

Trésorerie et équivalents de trésorerie

Definium Therapeutics, Inc. - Common Shares

Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.